IMI - Oral biopharmaceutics tools project - Evaluation of bottom-up PBPK prediction success part 3: Identifying gaps in system parameters by analysing In Silico performance across different compound classes. (2017)
Attributed to:
Rare disease use of clinical trial simulation for the chioce and optimization of study designs/Priomedchild Call/ER
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ejps.2016.09.037
PubMed Identifier: 27693299
Publication URI: http://europepmc.org/abstract/MED/27693299
Type: Journal Article/Review
Volume: 96
Parent Publication: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
ISSN: 0928-0987